hotspot -WSS

hotspot

author：explore 2025-08-28 03:34:17 - browse：7

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Peter Marks talks Operation Warp Speed for Rare Diseases

WSS

Criminal prosecution for violating HIPAA: an emerging threat

How doctors and nurses shape Google's AI

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

European regulators recommend Amylyx's ALS drug be rejected

European regulators consider appeal over Amylyx ALS drug

hotspot

hotspot

entertainment

Activists slam private health insurers over coverage restrictions

What the Wegovy shortage looks like for doctors — and for patients

ChatGPT in medicine: STAT answers readers' burning questions

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Duchenne breakthrough therapy leaves behind pioneering families

Military medical care influenced by rank and race, new study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Addiction experts warn against a second 'war on drugs'

Hollywood unions extend contract negotiations for actors

Akero's treatment for NASH falls short in cirrhosis study

leisure time

Life sciences deals on track to hit lowest point since 2017

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

How doctors and nurses shape Google's AI

Military medical care influenced by rank and race, new study finds

Readers respond to H5N1 and livestock movements, and more

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Wikipedia

hotspot

entertainment

focus